Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) — Working Capital to Net Assets Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has a Working Capital to Net Assets ratio of 30.5% as of March 2026. Working capital of CN¥3.47 Billion (current assets of CN¥5.79 Billion minus current liabilities of CN¥2.31 Billion) is measured against net assets of CN¥11.39 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Shijiazhuang Yiling Pharmaceutical Co Lt balance sheet quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Shijiazhuang Yiling Pharmaceutical Co Ltd Working Capital to Net Assets (2008–2025)
This chart shows how Shijiazhuang Yiling Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 18 annual periods from 2008 to 2025. As of March 2026, the ratio stands at 30.5%, reflecting working capital of CN¥3.47 Billion against net assets of CN¥11.39 Billion CNY. Check Shijiazhuang Yiling Pharmaceutical Co Lt tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Shijiazhuang Yiling Pharmaceutical Co Ltd from 2008 to 2025, covering 18 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is Shijiazhuang Yiling Pharmaceutical Co Lt worth.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 27.3% | CN¥3.00 Billion | CN¥10.98 Billion | CN¥5.21 Billion | CN¥2.21 Billion | ▲ +10.4 pp |
| 2024 | 16.9% | CN¥1.73 Billion | CN¥10.20 Billion | CN¥4.33 Billion | CN¥2.61 Billion | ▼ -1.4 pp |
| 2023 | 18.3% | CN¥2.10 Billion | CN¥11.44 Billion | CN¥6.54 Billion | CN¥4.45 Billion | ▼ -3.7 pp |
| 2022 | 22.0% | CN¥2.40 Billion | CN¥10.93 Billion | CN¥7.25 Billion | CN¥4.85 Billion | ▼ -7.1 pp |
| 2021 | 29.1% | CN¥2.64 Billion | CN¥9.07 Billion | CN¥5.60 Billion | CN¥2.96 Billion | ▼ -6.9 pp |
| 2020 | 36.0% | CN¥3.22 Billion | CN¥8.92 Billion | CN¥5.46 Billion | CN¥2.24 Billion | ▼ -17.6 pp |
| 2019 | 53.6% | CN¥4.26 Billion | CN¥7.95 Billion | CN¥5.07 Billion | CN¥806.43 Million | ▼ -1.1 pp |
| 2018 | 54.7% | CN¥4.13 Billion | CN¥7.56 Billion | CN¥4.90 Billion | CN¥764.66 Million | ▲ +4.9 pp |
| 2017 | 49.8% | CN¥3.54 Billion | CN¥7.11 Billion | CN¥4.15 Billion | CN¥607.29 Million | ▲ +16.4 pp |
| 2016 | 33.4% | CN¥1.78 Billion | CN¥5.33 Billion | CN¥2.53 Billion | CN¥747.83 Million | ▼ -0.1 pp |
| 2015 | 33.5% | CN¥1.61 Billion | CN¥4.83 Billion | CN¥2.32 Billion | CN¥707.42 Million | ▼ -5.9 pp |
| 2014 | 39.3% | CN¥1.74 Billion | CN¥4.42 Billion | CN¥2.24 Billion | CN¥504.64 Million | ▼ -18.3 pp |
| 2013 | 57.7% | CN¥2.46 Billion | CN¥4.26 Billion | CN¥2.70 Billion | CN¥239.93 Million | ▼ -9.0 pp |
| 2012 | 66.7% | CN¥2.56 Billion | CN¥3.84 Billion | CN¥2.69 Billion | CN¥130.22 Million | ▼ -9.2 pp |
| 2011 | 75.9% | CN¥2.81 Billion | CN¥3.70 Billion | CN¥3.18 Billion | CN¥373.98 Million | ▲ +43.0 pp |
| 2010 | 32.9% | CN¥358.73 Million | CN¥1.09 Billion | CN¥892.83 Million | CN¥534.10 Million | ▼ -3.6 pp |
| 2009 | 36.4% | CN¥288.06 Million | CN¥790.55 Million | CN¥928.81 Million | CN¥640.75 Million | ▲ +3.9 pp |
| 2008 | 32.5% | CN¥157.30 Million | CN¥484.03 Million | CN¥445.72 Million | CN¥288.42 Million | — |